161 related articles for article (PubMed ID: 15464833)
1. The effect of various liposome formulations on insulin penetration across Caco-2 cell monolayer.
Degim Z; Unal N; Eşsiz D; Abbasoglu U
Life Sci; 2004 Oct; 75(23):2819-27. PubMed ID: 15464833
[TBL] [Abstract][Full Text] [Related]
2. Investigation of liposome formulation effects on rivastigmine transport through human colonic adenocarcinoma cell line (CACO-2).
Degim Z; Mutlu NB; Yilmaz S; Eşsiz D; Nacar A
Pharmazie; 2010 Jan; 65(1):32-40. PubMed ID: 20187576
[TBL] [Abstract][Full Text] [Related]
3. New perspective for the treatment of Alzheimer diseases: liposomal rivastigmine formulations.
Mutlu NB; Değim Z; Yilmaz Ş; Eşsiz D; Nacar A
Drug Dev Ind Pharm; 2011 Jul; 37(7):775-89. PubMed ID: 21231901
[TBL] [Abstract][Full Text] [Related]
4. Permeation enhancer effect of chitosan and chitosan derivatives: comparison of formulations as soluble polymers and nanoparticulate systems on insulin absorption in Caco-2 cells.
Sadeghi AM; Dorkoosh FA; Avadi MR; Weinhold M; Bayat A; Delie F; Gurny R; Larijani B; Rafiee-Tehrani M; Junginger HE
Eur J Pharm Biopharm; 2008 Sep; 70(1):270-8. PubMed ID: 18492606
[TBL] [Abstract][Full Text] [Related]
5. Nanoparticle and liposome formulations of doxycycline: transport properties through Caco-2 cell line and effects on matrix metalloproteinase secretion.
Yücel C; Değim Z; Yilmaz S
Biomed Pharmacother; 2013 Jul; 67(6):459-67. PubMed ID: 23583191
[TBL] [Abstract][Full Text] [Related]
6. Correlation of in vitro and in vivo models for the oral absorption of peptide drugs.
Föger F; Kopf A; Loretz B; Albrecht K; Bernkop-Schnürch A
Amino Acids; 2008 Jun; 35(1):233-41. PubMed ID: 17726639
[TBL] [Abstract][Full Text] [Related]
7. Effect of simulated intestinal fluid on drug permeability estimation across Caco-2 monolayers.
Ingels F; Beck B; Oth M; Augustijns P
Int J Pharm; 2004 Apr; 274(1-2):221-32. PubMed ID: 15072798
[TBL] [Abstract][Full Text] [Related]
8. Facilitated nanoscale delivery of insulin across intestinal membrane models.
Woitiski CB; Sarmento B; Carvalho RA; Neufeld RJ; Veiga F
Int J Pharm; 2011 Jun; 412(1-2):123-31. PubMed ID: 21501675
[TBL] [Abstract][Full Text] [Related]
9. Absorption of poorly water soluble drugs subject to apical efflux using phospholipids as solubilizers in the Caco-2 cell model.
Kapitza SB; Michel BR; van Hoogevest P; Leigh ML; Imanidis G
Eur J Pharm Biopharm; 2007 Apr; 66(1):146-58. PubMed ID: 17071065
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo evaluation of a novel oral insulin formulation.
Ma EL; Ma H; Liu Z; Zheng GX; Duan MX
Acta Pharmacol Sin; 2006 Oct; 27(10):1382-8. PubMed ID: 17007747
[TBL] [Abstract][Full Text] [Related]
11. Transport of decursin and decursinol angelate across Caco-2 and MDR-MDCK cell monolayers: in vitro models for intestinal and blood-brain barrier permeability.
Madgula VL; Avula B; Reddy V L N; Khan IA; Khan SI
Planta Med; 2007 Apr; 73(4):330-5. PubMed ID: 17372866
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms for absorption enhancement of inhaled insulin by sodium taurocholate.
Johansson F; Hjertberg E; Eirefelt S; Tronde A; Hultkvist Bengtsson U
Eur J Pharm Sci; 2002 Oct; 17(1-2):63-71. PubMed ID: 12356421
[TBL] [Abstract][Full Text] [Related]
13. [Mechanisms of action of transportation of liposomes and chitosan-coated liposomes containing leuprolide across intestine and Caco-2 cell].
Guo JX; Ping QN; Dong J; Li ZR; Li CJ
Yao Xue Xue Bao; 2005 Jan; 40(1):65-70. PubMed ID: 15881330
[TBL] [Abstract][Full Text] [Related]
14. Hypoglycemic activity and oral bioavailability of insulin-loaded liposomes containing bile salts in rats: the effect of cholate type, particle size and administered dose.
Niu M; Lu Y; Hovgaard L; Guan P; Tan Y; Lian R; Qi J; Wu W
Eur J Pharm Biopharm; 2012 Jun; 81(2):265-72. PubMed ID: 22369880
[TBL] [Abstract][Full Text] [Related]
15. [The enhancing effect of tomato lectin modified liposomes of insulin on oral absorption in mice].
Zhang N; Ping QN; Xu WF
Yao Xue Xue Bao; 2004 May; 39(5):380-4. PubMed ID: 15338884
[TBL] [Abstract][Full Text] [Related]
16. [Enhancing effect of Ulex europaeus agglutinin I modified liposomes on oral insulin absorption in mice].
Zhang N; Ping QN; Xu WF
Yao Xue Xue Bao; 2004 Dec; 39(12):1006-10. PubMed ID: 15813031
[TBL] [Abstract][Full Text] [Related]
17. Permeability assessment for solid oral drug formulations based on Caco-2 monolayer in combination with a flow through dissolution cell.
Motz SA; Schaefer UF; Balbach S; Eichinger T; Lehr CM
Eur J Pharm Biopharm; 2007 May; 66(2):286-95. PubMed ID: 17156983
[TBL] [Abstract][Full Text] [Related]
18. The constituents of Cibotium barometz and their permeability in the human Caco-2 monolayer cell model.
Wu Q; Yang XW
J Ethnopharmacol; 2009 Sep; 125(3):417-22. PubMed ID: 19635547
[TBL] [Abstract][Full Text] [Related]
19. [Absorption of coptisine chloride and berberrubine across human intestinal epithelial by using human Caco-2 cell monolayers].
Ma L; Yang XW
Zhongguo Zhong Yao Za Zhi; 2007 Dec; 32(23):2523-7. PubMed ID: 18330249
[TBL] [Abstract][Full Text] [Related]
20. Liposomes containing cholesterol analogues of botanical origin as drug delivery systems to enhance the oral absorption of insulin.
Cui M; Wu W; Hovgaard L; Lu Y; Chen D; Qi J
Int J Pharm; 2015 Jul; 489(1-2):277-84. PubMed ID: 25957702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
